The cancer exome generated by alternative mRNA splicing dilutes predicted HLA class I epitope density.
Several studies have shown that cancers actively regulate alternative splicing. Altered splicing mechanisms in cancer lead to cancer-specific transcripts different from the pool of transcripts occurring only in healthy tissue. At the same time, altered presentation of HLA class I epitopes is frequen...
Guardado en:
Autores principales: | Thomas Stranzl, Mette V Larsen, Ole Lund, Morten Nielsen, Søren Brunak |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e87572c1611c4c92a881d62e69541aa4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses.
por: Mingjun Wang, et al.
Publicado: (2010) -
Reliable B cell epitope predictions: impacts of method development and improved benchmarking.
por: Jens Vindahl Kringelum, et al.
Publicado: (2012) -
Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan.
por: Morten Nielsen, et al.
Publicado: (2008) -
Human immune responses to H. pylori HLA Class II epitopes identified by immunoinformatic methods.
por: Songhua Zhang, et al.
Publicado: (2014) -
BCAS2 is involved in alternative mRNA splicing in spermatogonia and the transition to meiosis
por: Wenbo Liu, et al.
Publicado: (2017)